Patients in the European Union who have advanced or metastatic non-small cell lung cancer (NSCLC) now can be treated with Roche’s Tecentriq (atezolizumab). According to the European Commission marketing ... Read more

The past decade saw the development of several new therapies for non-small cell lung cancer (NSCLC), but little survival benefit for patients with advanced-stage disease, according to a new ... Read more

Genentech recently announced positive results for its cancer immunotherapy Tecentriq (atezolizumab) being tested in the Phase 3 clinical trial OAK (NCT02008227). Tecentriq is a monoclonal antibody designed to bind to an immune checkpoint ... Read more

BeyondSpring Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) is allowing enrollment in the Phase 1/2 clinical trial to access the company’s drug plinabulin in combination with nivolumab for the treatment ... Read more

For 40 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood by offering advanced technology, treatment and early detection. For residents ... Read more

An early benefit assessment indicated that while Portrazza (necitumumab) increases overall patient survival, additional negative effects reduce the impact of this outcome and result in only a minor added benefit ... Read more

Disclaimer:

Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Pin It on Pinterest

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more